Browse > Home / Pharmacy Industry News / Full Testing Recommended For Medicinal Products Susceptible To ‘Dose Dumping’

Full Testing Recommended For Medicinal Products Susceptible To ‘Dose Dumping’

September 24, 2009

Controlled set free pills and capsules that become visible a tendency in the standard laboratory test near “dose dumping” - releasing their medicine in a faster and potentially full of risk habits in patients who have consumed alcohol - should be withheld from the market until proven safe with testing in people. That’s the close of a retrace of existing studies in the September-October issue of ACS’ Molecular Pharmaceutics, a bi-monthly journal.

In the article, Hans Lennernäs analyzed the gastrointestinal factors that may contribute to dose dumping when a vulnerable formulation interacts with alcohol present in the stomach. However, these factors are highly variable and depend on individual tippling behavior, whether food is propitious in the relish, and other circumstances. That makes it “within a little impossible” to predict whether a patient will actual feeling any overdose as a be the effect of dose dumping.

Lennernäs thus concludes that which time laboratory testing of a product indicates that the drug will be released more quickly than intended, the product also should subsist pure in humans, or it should have existence re-formulated. Indeed, Lennernäsession believes that lab testing upper a two hour period in a range of alcohol strengths is some “absolute minimum standard” in screening for dose dumping because products with a enigma in the lab may also be dangerous to patients. Lennernäs cites as an example a formulation of the misery medication hydromorphone, what one. was removed from the U.S. market whereas testing revealed that spirits of wine intake caused the risk of overdose. He noted, still, that there is generally a generic oxycodone product on the market in the European Union which will “most that may be liked” lead to dose dumping in patients.

ARTICLE: “Ethanol-Drug Absorption Interaction: Potential for a Significant Effect on the Plasma Pharmacokinetics of Ethanol Vulnerable Formulations”

Source:
Michael Woods
American Chemical Society

View drug information on Oxycodone and Aspirin.

Written by Samanta · Filed Under Pharmacy Industry News